Literature DB >> 5587694

[Diffuse interstitial fibrosis of the lung in Hodgkin's disease treated by high doses of endoxan].

R André, H Rochant, B Dreyfus, G Duhamel, J C Péchère.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5587694

Source DB:  PubMed          Journal:  Bull Mem Soc Med Hop Paris        ISSN: 0366-1334


× No keyword cloud information.
  7 in total

Review 1.  Cyclophosphamide toxicity. Characterising and avoiding the problem.

Authors:  L H Fraiser; S Kanekal; J P Kehrer
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

2.  Wegener's granulomatosis.

Authors:  K E Sack
Journal:  West J Med       Date:  1989-03

Review 3.  Lung damage from cytotoxic drugs.

Authors:  C H Collis
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  Fatal pneumopathy after cytostatic treatment for leukemia in children.

Authors:  K M Müller; R Menne; W Hüther; H Gröbe
Journal:  J Cancer Res Clin Oncol       Date:  1979-07-27       Impact factor: 4.553

5.  Sclerosing alveolitis induced by cyclophosphamide. Ultrastructural observations on alveolar injury and repair.

Authors:  V E Gould; J Miller
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

6.  Cyclophosphamide pneumonitis.

Authors:  G J Mark; A Lehimgar-Zadeh; B D Ragsdale
Journal:  Thorax       Date:  1978-02       Impact factor: 9.139

7.  Cyclophosphamide-induced lung damage in mice: protection by a small preliminary dose.

Authors:  C H Collis; C M Wilson; J M Jones
Journal:  Br J Cancer       Date:  1980-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.